CryoMass Partners with Cannabis Powerhouse LEEF to Deploy Its Cryo Separation Technology
May 16, 2024 07:10 ET
|
Cryomass Technologies
CryoMass announced the sale of its second CryoSift Separator™ production model for US$1.2 million.
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
May 15, 2024 16:20 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate...
CryoMass Announces Sale of First Production Model to be deployed in Canada
May 14, 2024 07:10 ET
|
Cryomass Technologies
The transaction we are announcing today is the first of such Unit sales for CAD$1.62 million, which will be deployed in Canada.
Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024
April 24, 2024 22:11 ET
|
Association québécoise des technologies (AQT)
Jean Magny, PDG de Genius Solutions est élu PDG de l’année AQT – Banque Nationale 2024Charlevoix (Québec), le 24 avril 2024 – C’est avec fierté que l’AQT
Global Vaccine Adjuvants Market Size To Worth USD 1.51 Billion By 2033 | CAGR of 3.9%
April 17, 2024 08:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , April 17, 2024 (GLOBE NEWSWIRE) -- The Global Vaccine Adjuvants Market Size is to Grow from USD 1.03 Billion in 2023 to USD 1.51 Billion by 2033, at a Compound Annual...
Bion Announces Voluntary Share Surrender
April 02, 2024 08:34 ET
|
BION ENVIRONMENTAL TECHNOLOGIES INC
New York, NY, April 02, 2024 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a leader in advanced livestock waste treatment technology and premium sustainable beef,...
MannKind Announces CFO Transition
March 26, 2024 16:05 ET
|
MannKind
MANNKIND ANNOUNCES CFO TRANSITION
Valneva Initiates Phase 1 Trial of Second-Generation Zika Vaccine Candidate
March 26, 2024 02:00 ET
|
VALNEVA
Saint-Herblain (France), March 26, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the initiation of a Phase 1 clinical trial to investigate the ...
Bion Applies for OMRI Listing for Commercial 10-0-0 Nitrogen Fertilizer
March 12, 2024 10:44 ET
|
BION ENVIRONMENTAL TECHNOLOGIES INC
New York, NY, March 12, 2024 (GLOBE NEWSWIRE) -- Bion Environmental Technologies, Inc. (OTC QB: BNET), a developer of advanced livestock waste treatment and resource recovery technology, announced...
Vaccine Adjuvants Market to Reach $1.5Billion Globally, By 2032 at 4% CAGR: Allied Market Research
March 12, 2024 09:02 ET
|
Allied Analytics LLP
Wilmington, New Castle, Delaware, March 12, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Vaccine Adjuvants Market by Product Type (Immunostimulants and Vehicles...